Dr. Stephen G. Schwartz

• 
  www.radthemag.com/program/read/author_overview.asp?id=5 - [Cached Version]
  Published on: 9/4/2008    Last Visited: 9/4/2008  

  Stephen G. Schwartz, MD
  ...
  Stephen G. Schwartz, MD is assistant professor of clinical ophthalmology at the University of Miami Miller School of Medicine and medical director and division chief of the Bascom Palmer Eye Institute Retina Center at Naples in Naples, FL. Before joining the faculty at Bascom Palmer, he served as assistant professor of ophthalmology and program director at Virginia Commonwealth University, Medical College of Virginia Campus, in Richmond, VA.He is a board-certified ophthalmologist specializing in diseases and surgery of the vitreous, retina, and macula, including age-related macular degeneration, diabetic retinopathy, retinal detachment, retinal vascular disease, and ocular trauma.He is a graduate of Cornell University and New York University School of Medicine.He completed ophthalmology residency training at New York University School of Medicine, and retina fellowship training at Baylor College of Medicine.

• 
  www.gulfshorelife.com/Articles/Gulfshore-Life/2006/Summ - [Cached Version]
  Published on: 1/1/2006    Last Visited: 8/5/2007  

  "There's been a lot of progress in the treatment of this disease even in the last 18 months," says Dr. Stephen G. Schwartz, a board-certified ophthalmologist at the Bascom Palmer Eye Institute in Naples.
  
  There have been several major advances over the last two years in the treatment of the "wet" form of AMD, so named because it involves bleeding in the macular, the central part of the retina."Dry" AMD, which accounts for about 80 percent of the cases, progresses more slowly.
  
  In December 2004, the FDA approved a drug called Macugen, which creates a chemical blockade of leaking blood vessels and "immediately changed how this disease was treated," according to Schwartz.Then came Lucentis, a competitor to Macugen that has shown promising results in clinical trials but awaits FDA approval.Both are injected into the eye.
  
  "The third major step forward happened in the last 18 months," Schwartz says."Avastin, a cancer drug approved by the FDA to treat cancer intravenously, was found to have some efficacy in treating macular degeneration."
  
  Avastin's effectiveness was discovered by researchers at Bascom Palmer's headquarters at the University of Miami Miller School of Medicine.
  
  "They tried putting the drug in the eye, even though it was never intended to go in the eye, and it was more successful than anybody had expected," Schwartz says.

• 
  www.preventblindness.org/research/recipients_2005_2006. - [Cached Version]
  Published on: 1/1/2005    Last Visited: 2/19/2009  

  Stephen G. Schwartz, MD Assistant Professor of Clinical Ophthalmology University of Miami

• 
  tebrotherhood.org/index.php/themes/index.php?module=Pag - [Cached Version]
  Published on: 2/26/2008    Last Visited: 6/16/2008  

  Steven Schwartz

• 
  www.templeemanuelkingston.org/folks01a.html - [Cached Version]
  Published on: 1/11/2008    Last Visited: 1/11/2008  

  Dr. Steven Schwartz

• 
  www.radthemag.com/program/read/author_profile.asp?id=55 - [Cached Version]
  Published on: 12/1/2007    Last Visited: 12/1/2007  

  Stephen G. Schwartz, MD

• 
  www.preventblindness.org/Florida/FL_research_news_0403. - [Cached Version]
  Published on: 4/3/2006    Last Visited: 3/5/2007  

  Prevent Blindness Florida Board Member, Stephen G. Schwartz, MD, from the University of Miami, Miller School of Medicine and the Bascom Palmer Eye Institute will present his work "Glucocorticoid Receptor Polymorphisms and Corticosteroid-Induced Glaucoma."
  ...
  "We are so excited to be able to provide assistance to Dr. Schwartz and his team in this battle to save sight," said Sarah Jordan-Holmes, CRFE, President & CEO of Prevent Blindness Florida.

• 
  www.asseenfromhere.com/ - [Cached Version]
  Last Visited: 7/4/2007  

  Stephen G. Schwartz, M.D.Assistant Professor of Clinical OphthalmologyJules Stein Eye Institute,

• 
  2004 VSO Annual Meeting - [Cached Version]
  Published on: 6/4/2003    Last Visited: 2/12/2004  

  Stephen G. Schwartz, M.D.Assistant Professor, Department of OphthalmologyVirginia Commonwealth University, Medical College of Virginia Campus

• 
  2005 Investigator Award Recipients - [Cached Version]
  Published on: 5/31/2005    Last Visited: 2/24/2009  

  Stephen G. Schwartz, MD, at the University of Miami, Miller School of Medicine and the Bascom Eye Institute has also received an Investigator Award for his work on the study of corticosteroids.

Page:  1 2 3 4